Stay updated with breaking news from Erytech Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phaxiam Therapeutics says it has notified the Nasdaq Stock Market of its intention to voluntarily delist its American Depositary Shares representing its ordinary shares, which should be effective...
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The
04.10.2023 - PHAXIAM Receives Compliance Notice from Nasdaq Lyon (France) et Cambridge (MA, US), October 4, 2023, at 10:05 pm CEST – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), today announced that it has received confirmation from Nasdaq that it has ...
Pharmaceutical companies are investing heavily in the Acute Lymphoblastic Leukemia market, resulting in an expanding range of treatment options and a brighter outlook for patients.Wilmington, Delaware, United States, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The acute lymphoblastic leukemia market was estimated to have acquired US$ 2.2 billion in 2021. It is anticipated to register a 7.6% CAGR from 2022 to 2031 and by 2031; the market is likely to gain US$ 4.5 billion
According to Precedence Research, the global acute lymphocytic leukaemia therapeutics market size is projected to surpass around USD 8.29 billion by 2032...